X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (31) 31
humans (30) 30
female (29) 29
oncology (26) 26
animals (23) 23
article (22) 22
cell line, tumor (20) 20
ovarian cancer (18) 18
mice (16) 16
ovarian neoplasms - pathology (16) 16
xenograft model antitumor assays (15) 15
ovarian neoplasms - metabolism (13) 13
mice, nude (12) 12
cancer (11) 11
ovarian neoplasms - drug therapy (10) 10
angiogenesis (9) 9
kaplan-meier estimate (9) 9
obstetrics & gynecology (9) 9
antineoplastic agents - pharmacology (8) 8
adult (7) 7
aged (7) 7
carcinoma (7) 7
cell proliferation - drug effects (7) 7
expression (7) 7
metastasis (7) 7
ovarian neoplasms - mortality (7) 7
analysis (6) 6
apoptosis - drug effects (6) 6
middle aged (6) 6
signal transduction - drug effects (6) 6
young adult (6) 6
aged, 80 and over (5) 5
apoptosis (5) 5
breast-cancer (5) 5
disease progression (5) 5
gene expression regulation, neoplastic - drug effects (5) 5
immunohistochemistry (5) 5
tumors (5) 5
bevacizumab (4) 4
blotting, western (4) 4
care and treatment (4) 4
catecholamines (4) 4
cell survival - drug effects (4) 4
cells (4) 4
disease models, animal (4) 4
drug resistance, neoplasm (4) 4
growth (4) 4
kinase (4) 4
norepinephrine - metabolism (4) 4
ovarian-cancer (4) 4
research (4) 4
resistance (4) 4
retrospective studies (4) 4
treatment outcome (4) 4
uterine cancer (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
biomarkers (3) 3
carcinoma - mortality (3) 3
carcinoma - pathology (3) 3
cell biology (3) 3
cell proliferation (3) 3
chemotherapy (3) 3
disease-free survival (3) 3
endometrial cancer (3) 3
health aspects (3) 3
hematology, oncology and palliative medicine (3) 3
in-vivo (3) 3
macrophages (3) 3
macrophages - metabolism (3) 3
molecular targeted therapy (3) 3
mutation (3) 3
neovascularization, pathologic - drug therapy (3) 3
neovascularization, pathologic - pathology (3) 3
ovarian neoplasms - genetics (3) 3
paclitaxel - pharmacology (3) 3
prognosis (3) 3
proto-oncogene proteins c-akt - metabolism (3) 3
tumor-growth (3) 3
uterine neoplasms - drug therapy (3) 3
women (3) 3
activation (2) 2
adjuvant treatment (2) 2
angiogenesis inhibitors - administration & dosage (2) 2
angiogenesis inhibitors - pharmacology (2) 2
animal models (2) 2
anti-vegf therapy (2) 2
antibodies, monoclonal - pharmacology (2) 2
antineoplastic agents, phytogenic - pharmacology (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - pharmacology (2) 2
aspirin (2) 2
biomarkers, tumor (2) 2
biomarkers, tumor - metabolism (2) 2
carcinoma - metabolism (2) 2
carcinoma, ovarian epithelial (2) 2
cell death (2) 2
cell survival (2) 2
chemokine ccl2 - metabolism (2) 2
chemotaxis, leukocyte - physiology (2) 2
clear cell carcinoma (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gynecologic Oncology, ISSN 0090-8258, 07/2018, Volume 150, Issue 1, pp. 1 - 2
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 01/2019, Volume 152, Issue 1, pp. 31 - 37
Evaluate the impact of clinicopathologic characteristics and adjuvant treatment on survival outcomes in early stage uterine carcinosarcoma patients. We... 
Uterine carcinosarcoma | Prognostic factors | Treatment | ONCOLOGY | UTERUS | SARCOMA | TUMOR | IFOSFAMIDE | CANCER | OBSTETRICS & GYNECOLOGY
Journal Article
Obstetrics and Gynecology Clinics of North America, ISSN 0889-8545, 03/2019, Volume 46, Issue 1, pp. 67 - 88
Ovarian cancer treatment continues to evolve. Despite aggressive surgery and chemotherapy, most women will ultimately die from disease. Improvement in disease... 
Clinical trials | Cytoreduction | Immunotherapy | PARP inhibitor | Bevacizumab | Ovarian cancer | PRIMARY PERITONEAL CANCER | 1ST-LINE CHEMOTHERAPY | FALLOPIAN-TUBE | OPEN-LABEL | OLAPARIB MAINTENANCE THERAPY | OBSTETRICS & GYNECOLOGY | PHASE-III TRIAL | NEOADJUVANT CHEMOTHERAPY | DOUBLE-BLIND | PACLITAXEL PLUS CARBOPLATIN | RECURRENT EPITHELIAL OVARIAN
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 723 - 723
Objectives: Tumor-associated macrophage infiltration is associated with poor prognosis, making macrophage depletion an ideal therapy. This study aims to... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 5_suppl, pp. 8 - 8
8 Background: The composition of the vaginal microbiome has been shown to affect clearance of HPV virus and transformation to invasive cancer. Clinical studies... 
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 05/2014, Volume 20, Issue 10, pp. 2740 - 2750
Journal Article
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. 2165 - 2165
Journal Article
Cancer Research, ISSN 0008-5472, 10/2014, Volume 74, Issue 19 Supplement, pp. 3511 - 3511
Journal Article
Cancer Research, ISSN 0008-5472, 10/2014, Volume 74, Issue 19 Supplement, pp. 2982 - 2982
Journal Article
Cancer Research, ISSN 0008-5472, 10/2014, Volume 74, Issue 19 Supplement, pp. 2983 - 2983
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 03/2019, Volume 152, Issue 3, pp. 554 - 559
To evaluate surgical complexity scores (SCS) and minimally invasive surgery (MIS) at interval debulking surgery (IDS) in advanced epithelial ovarian cancer... 
Women | Medical research | Analysis | Adjuvant treatment | Medicine, Experimental | Laparoscopic surgery | Laparoscopy | Ovarian cancer | Cancer
Journal Article
Journal Article
Cancer Cell, ISSN 1535-6108, 11/2015, Volume 28, Issue 5, pp. 610 - 622
Journal Article
Cancer Research, ISSN 0008-5472, 10/2014, Volume 74, Issue 19 Supplement, pp. 2995 - 2995
Journal Article
Cell Reports, ISSN 2211-1247, 12/2015, Volume 13, Issue 11, pp. 2395 - 2402
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.